Where does Nautilus Biotechnology, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nautilus Biotechnology, Inc. ranks #23,053 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nautilus Biotechnology, Inc. hold?

Nautilus Biotechnology, Inc. holds 12 US utility patents granted between 2019 and 2023, spanning 8 technology areas.

What is Nautilus Biotechnology, Inc.'s Innovation Score?

Nautilus Biotechnology, Inc. has an Innovation Score of 47.2 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nautilus Biotechnology, Inc. focus on?

Nautilus Biotechnology, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 11 patents, ranking #1,329 of 7,863 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Nautilus Biotechnology, Inc.'s patent grant rate increasing or decreasing?

Nautilus Biotechnology, Inc.'s recent grant velocity is +1000% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Nautilus Biotechnology, Inc.'s patents?

Nautilus Biotechnology, Inc.'s patents average 26.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nautilus Biotechnology, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nautilus Biotechnology, Inc.

USPTO PatentsView assignee record - 12 granted patents across 8 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nautilus ranks #23,053 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 8 technology areas.

#23,053
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.2/100): 26.1
avg claims per patent: +1000%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23053 · US Corporation #23,053 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,053/49,997
PHOTO-FINISH National Presort
CPC-NARROW G01N · 8 areas
INNOV-PAR 47.2/100
CLAIMS-DENSE 26.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1000% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Presort, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nautilus’s 47.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (19%) Velocity 13.3 pts (28%) Breadth 10.0 pts (21%) Claim depth 15.0 pts (32%)

Qualcomm Incorporated · highest

85
Nautilus Biotechnology · this assignee

47
3D Lighting… · lowest

7

What this shows Nautilus's Innovation Score is 47.2/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nautilus?

Each dot is one of Nautilus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nautilus’s own 26.1 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nautilus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nautilus's grants concentrate

Nautilus Biotechnology, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 91.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2019. By volume, Nautilus sits between National Presort, LLC and Nellix, Inc..

Nautilus's three-year grant acceleration

Nautilus Biotechnology, Inc. shows 8 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

National Presort

12
National Security

12
Nationwide 5

12
Naturalmotion

12
Nautilus Data

12
Navidea Biopharma…

12
Navitas Systems

12
Nellix

12
Nautilus Biotechn… ◀

12

What this shows Nautilus holds 12 patents at rank #23,077, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nautilus

By rank, the assignees closest to #23,077 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Nautilus's primary technology class.

Nautilus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Nautilus Biotechnology, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	8.3%
2021	3	25.0%
2022	4	33.3%
2023	4	33.3%

Which technologies does Nautilus Biotechnology, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 9

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07K - Peptides 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nautilus Biotechnology, Inc.'s patent record in context - here's where to go next.

Nautilus Biotechnology, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 91.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #23,053 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nautilus Biotechnology, Inc. against National Presort, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.